Overprescribing antibiotics breeds antibiotic resistance. A new tool aims to lower a notably high rate of such prescriptions ...
If you’ve spent any time on social media recently (and especially if you’re a man) you’ve probably seen the videos we’re ...
Pembrolizumab plus weekly paclitaxel, with investigator-choice bevacizumab, achieved statistically significant PFS and OS improvements, addressing a high unmet need in platinum-resistant ovarian ...
C2N Diagnostics, LLC (“C2N”), a specialty diagnostics company with a vision to bring Clarity Through Innovation®, has reached an agreement with BeauBrain Healthcare that brings its breakthrough ...
Over the past decade, robotic platforms have become one of the most visible symbols of innovation in spine surgery. Health systems across the country have invested heavily in advanced navigation and ...
C2N Diagnostics, LLC ("C2N"), a specialty diagnostics company with a vision to bring Clarity Through Innovation(R), has reached an agreement with BeauBrain Healthcare that brings its breakthrough ...
He is the lead principal investigator of the ALLEGORY study and the lead author and he has also presented the results last Friday at SLEuro. Today, Dr. Richard Furie will take us again through the ...
Cardiovascular disease is the leading cause of death in North Carolina, and effective management of the condition is essential to improving residents’ quality of life. Cardiovascular conditions are a ...
Imaging suggests HCC, yet cirrhosis is uncertain—see why biopsy matters and how AFP, spread, and liver function shape treatment. For oncology clinicians, the Liver Imaging-Reporting and Data System ...
The X logo appears on a smartphone screen. (Photo by Nikolas Kokovlis/NurPhoto via Getty Images) (NurPhoto via Getty Images) When X's engineering team published the code that powers the platform's ...
The EU is threatening to take action against the social media company. It could be the start of a global reckoning. Katie is a UK-based news reporter and features writer. Officially, she is CNET's ...